0
Clinical Investigations: SURGERY |

Sustained Improvements in Dyspnea and Pulmonary Function 3 to 5 Years After Lung Volume Reduction Surgery*

Sarah Appleton; Robert Adams; Samuel Porter; Morris Peacock; Richard Ruffin
Author and Funding Information

*From the Departments of Medicine (Ms. Appleton, and Drs. Adams and Ruffin) and Surgery (Mr. Peacock), University of Adelaide, The Queen Elizabeth Hospital Campus, Woodville, SA, Australia; private practice (Dr. Porter), Adelaide, SA, Australia.

Correspondence to: Robert Adams, MBBS, MD, Department of Medicine, The Queen Elizabeth Hospital, 28 Woodville Rd, Woodville, SA, Australia 5011; e-mail: robert.adams@nwahs.sa.gov.au



Chest. 2003;123(6):1838-1846. doi:10.1378/chest.123.6.1838
Text Size: A A A
Published online

Objectives: To determine long-term survival rates of patients who underwent lung volume reduction surgery (LVRS) for emphysema and the factors associated with longer survival, and to evaluate levels of perceived dyspnea and health-related quality of life (HRQL) after a follow-up period of 3 to 5.5 years.

Design: Retrospective observational study.

Setting: Academic medical center

Methods: Telephone and postal surveys were used to obtain patient dyspnea scores and HRQL scores. Hospital databases and state registries were searched to determine patient survival and pulmonary function.

Results: Of 54 patients undergoing LVRS, 29 patients (18 men and 11 women) were available for follow-up, which ranged from 36 to 66 months (mean ± SE, 51 ± 1.5 months). There was significant sustained improvement in modified Medical Research Council scores compared to pre-LVRS: 2.19 ± 0.19 vs 2.88 ± 0.14 (p = 0.0000). Eleven of 22 patients demonstrated an increase in all three Mahler baseline dyspnea index grades of at least one level. Baseline body mass index (BMI) and post-LVRS length of stay (LOS) were significantly associated with survival: survivor vs deceased baseline BMI, 24.2 ± 0.6 vs 21.4 ± 0.5 (p = 0.002), and post-LVRS LOS, 15.4 ± 1.7 days vs 28.7 ± 5.3 days (p = 0.015). Compared to pre-LVRS, 20 patients with mean follow-up time of 45 months demonstrated significant sustained improvements in FEV1 percentage of predicted (31.4 ± 2.1% vs 39.8 ± 3.5%, p = 0.038), total lung capacity percentage of predicted (136 ± 4% vs 122 ± 3%, p = 0.0004), and residual volume percentage of predicted (237 ± 14% vs 172 ± 11%, p = 0.0001). Patient HRQL measured using the Dartmouth Primary Care Co-operative Quality of Life questionnaire was more favorable than that reported in aged-care settings. Caregiver burden scale scores indicate caring for a recipient of LVRS carries similar burden to that for caring for individuals with other chronic illnesses.

Conclusions: In this population, a majority of the LVRS patients survived for ≥ 3 years. Among survivors, dyspnea and lung function benefits were seen. Baseline BMI and postoperative LOS were significantly associated with survival.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Pulmonary Predictors of Incident Diabetes in Smokers. Chronic Obstr Pulm Dis 2016;3(4):739-747.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543